A detailed history of Ronald Blue Trust, Inc. transactions in Boston Scientific Corp stock. As of the latest transaction made, Ronald Blue Trust, Inc. holds 4,425 shares of BSX stock, worth $452,943. This represents 0.01% of its overall portfolio holdings.

Number of Shares
4,425
Previous 15,077 70.65%
Holding current value
$452,943
Previous $1.35 Million 70.65%
% of portfolio
0.01%
Previous 0.02%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 30, 2025

SELL
$83.62 - $91.5 $890,720 - $974,658
-10,652 Reduced 70.65%
4,425 $395,000
Q4 2024

Jan 22, 2025

BUY
$83.62 - $91.5 $383,397 - $419,527
4,585 Added 43.7%
15,077 $1.35 Million
Q3 2024

Oct 17, 2024

BUY
$72.96 - $84.0 $366,040 - $421,428
5,017 Added 91.63%
10,492 $879,000
Q2 2024

Jul 18, 2024

BUY
$67.33 - $77.71 $164,083 - $189,379
2,437 Added 80.22%
5,475 $421,000
Q1 2024

May 01, 2024

BUY
$57.6 - $68.62 $89,452 - $106,566
1,553 Added 104.58%
3,038 $208,000
Q4 2023

Jan 18, 2024

BUY
$48.64 - $57.81 $6,906 - $8,209
142 Added 10.57%
1,485 $79,000
Q3 2023

Oct 11, 2023

BUY
$50.19 - $54.68 $3,914 - $4,265
78 Added 6.17%
1,343 $73,000
Q2 2023

Jul 14, 2023

SELL
$49.72 - $54.64 $45,294 - $49,777
-911 Reduced 41.87%
1,265 $63,000
Q1 2023

Apr 17, 2023

BUY
$45.09 - $50.03 $1,938 - $2,151
43 Added 2.02%
2,176 $100,000
Q4 2022

Jan 17, 2023

SELL
$39.56 - $47.22 $3,639 - $4,344
-92 Reduced 4.13%
2,133 $83,000
Q3 2022

Oct 21, 2022

SELL
$36.71 - $109.66 $14,684 - $43,864
-400 Reduced 15.24%
2,225 $83,000
Q2 2022

Aug 09, 2022

BUY
$35.24 - $47.1 $92,505 - $123,637
2,625 New
2,625 $116,000

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $147B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Ronald Blue Trust, Inc. Portfolio

Follow Ronald Blue Trust, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ronald Blue Trust, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Ronald Blue Trust, Inc. with notifications on news.